{"id":"https://openalex.org/W2000375621","doi":"https://doi.org/10.1002/1097-0142(19950201)75:3<815::aid-cncr2820750311>3.0.co;2-r","title":"A phase III randomized study of oral verapamil as a chemosensitizer to reverse drug resistance in patients with refractory myeloma. A southwest oncology group study","display_name":"A phase III randomized study of oral verapamil as a chemosensitizer to reverse drug resistance in patients with refractory myeloma. A southwest oncology group study","publication_year":1995,"publication_date":"1995-02-01","ids":{"openalex":"https://openalex.org/W2000375621","doi":"https://doi.org/10.1002/1097-0142(19950201)75:3<815::aid-cncr2820750311>3.0.co;2-r","mag":"2000375621","pmid":"https://pubmed.ncbi.nlm.nih.gov/7828131"},"language":"en","primary_location":{"id":"doi:10.1002/1097-0142(19950201)75:3<815::aid-cncr2820750311>3.0.co;2-r","doi":"https://doi.org/10.1002/1097-0142(19950201)75:3<815::aid-cncr2820750311>3.0.co;2-r","is_oa":true,"landing_page_url":"https://doi.org/10.1002/1097-0142(19950201)75:3<815::aid-cncr2820750311>3.0.co;2-r","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/1097-0142%2819950201%2975%3A3%3C815%3A%3AAID-CNCR2820750311%3E3.0.CO%3B2-R","source":{"id":"https://openalex.org/S126033908","display_name":"Cancer","issn_l":"0008-543X","issn":["0008-543X","1045-7410","1097-0142"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/1097-0142%2819950201%2975%3A3%3C815%3A%3AAID-CNCR2820750311%3E3.0.CO%3B2-R","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5056492087","display_name":"William S. Dalton","orcid":"https://orcid.org/0000-0003-2582-0454","observed_orcids":["https://orcid.org/0000-0003-2582-0454"]},"institutions":[{"id":"https://openalex.org/I4390039223","display_name":"University of Arizona Cancer Center","ror":"https://ror.org/04tvx8690","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039223"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"William S. Dalton","raw_affiliation_strings":["University of Arizona Cancer Center, Tucson","University of Arizona, Cancer Center Tucson, Arizona"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Arizona Cancer Center, Tucson","institution_ids":["https://openalex.org/I4390039223"]},{"raw_affiliation_string":"University of Arizona, Cancer Center Tucson, Arizona","institution_ids":["https://openalex.org/I4390039223"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103408877","display_name":"John J. Crowley","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John J. Crowley","raw_affiliation_strings":["Southwest Oncology Group Statistical Center, Seattle, Washington"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Southwest Oncology Group Statistical Center, Seattle, Washington","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112804533","display_name":"SE Salmon","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4390039223","display_name":"University of Arizona Cancer Center","ror":"https://ror.org/04tvx8690","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039223"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sydney S. Salmon","raw_affiliation_strings":["University of Arizona Cancer Center, Tucson, Arizona"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Arizona Cancer Center, Tucson, Arizona","institution_ids":["https://openalex.org/I4390039223"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111756977","display_name":"Thomas M. Grogan","orcid":"https://orcid.org/0009-0003-3008-1876","observed_orcids":["https://orcid.org/0009-0003-3008-1876"]},"institutions":[{"id":"https://openalex.org/I4390039223","display_name":"University of Arizona Cancer Center","ror":"https://ror.org/04tvx8690","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039223"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Thomas M. Grogan","raw_affiliation_strings":["University of Arizona Cancer Center, Tucson, Arizona"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Arizona Cancer Center, Tucson, Arizona","institution_ids":["https://openalex.org/I4390039223"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057589827","display_name":"Leslie Rodgers Laufman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210165485","display_name":"Columbus Community Clinical Oncology Program","ror":"https://ror.org/05rvv6a54","country_code":"US","type":"other","lineage":["https://openalex.org/I4210165485"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Leslie Rodgers Laufman","raw_affiliation_strings":["Columbus Community Clinical Oncology Program, Columbus, Ohio"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Columbus Community Clinical Oncology Program, Columbus, Ohio","institution_ids":["https://openalex.org/I4210165485"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063294358","display_name":"Geoffrey R. Weiss","orcid":"https://orcid.org/0000-0001-8226-5552","observed_orcids":["https://orcid.org/0000-0001-8226-5552"]},"institutions":[{"id":"https://openalex.org/I165951966","display_name":"The University of Texas at San Antonio Health Science Center","ror":"https://ror.org/02f6dcw23","country_code":"US","type":"education","lineage":["https://openalex.org/I165951966","https://openalex.org/I45438204"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Geoffrey R. Weiss","raw_affiliation_strings":["University of Texas Health Science Center at San Antonio, San Antonio, Texas"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Texas Health Science Center at San Antonio, San Antonio, Texas","institution_ids":["https://openalex.org/I165951966"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5036980145","display_name":"John D. Bonnet","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210102330","display_name":"Baylor Scott & White Medical Center - Temple","ror":"https://ror.org/017cm6884","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210102330","https://openalex.org/I4210160418"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John D. Bonnet","raw_affiliation_strings":["Scott & White Clinic, Temple, Texas","Scott and White Clinic, Temple, Texas"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Scott & White Clinic, Temple, Texas","institution_ids":["https://openalex.org/I4210102330"]},{"raw_affiliation_string":"Scott and White Clinic, Temple, Texas","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5056492087"],"corresponding_institution_ids":["https://openalex.org/I4390039223"],"apc_list":{"value":4790,"currency":"USD","value_usd":4790},"apc_paid":null,"fwci":5.0647,"has_fulltext":true,"cited_by_count":156,"citation_normalized_percentile":{"value":0.95836504,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"75","issue":"3","first_page":"815","last_page":"820"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.9208999872207642,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.9208999872207642,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.0746999979019165,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":0.9330000281333923},{"id":"https://openalex.org/keywords/verapamil","display_name":"verapamil","score":0.8690000176429749},{"id":"https://openalex.org/keywords/chemosensitizers","display_name":"chemosensitizers","score":0.9010000228881836},{"id":"https://openalex.org/keywords/multidrug-resistance","display_name":"multidrug resistance","score":0.9539999961853027},{"id":"https://openalex.org/keywords/reversal-of-drug-resistance","display_name":"drug resistance reversal","score":0.7549999952316284},{"id":"https://openalex.org/keywords/vad-chemotherapy","display_name":"VAD chemotherapy","score":0.9120000004768372},{"id":"https://openalex.org/keywords/vincristine","display_name":"vincristine","score":0.9639999866485596},{"id":"https://openalex.org/keywords/doxorubicin","display_name":"doxorubicin","score":0.9990000128746033},{"id":"https://openalex.org/keywords/dexamethasone","display_name":"dexamethasone","score":0.9990000128746033},{"id":"https://openalex.org/keywords/p-glycoprotein","display_name":"P-glycoprotein","score":0.9399999976158142},{"id":"https://openalex.org/keywords/overall-response-rate","display_name":"overall response rate","score":0.6970000267028809},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9049999713897705},{"id":"https://openalex.org/keywords/myelosuppression","display_name":"myelosuppression","score":0.9649999737739563}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9098058938980103},{"id":"https://openalex.org/C2776375370","wikidata":"https://www.wikidata.org/wiki/Q5090615","display_name":"Chemosensitizer","level":4,"score":0.8461778163909912},{"id":"https://openalex.org/C2777022698","wikidata":"https://www.wikidata.org/wiki/Q410291","display_name":"Verapamil","level":3,"score":0.6311654448509216},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6159418821334839},{"id":"https://openalex.org/C2779429289","wikidata":"https://www.wikidata.org/wiki/Q408977","display_name":"Vincristine","level":4,"score":0.5530532002449036},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.525088906288147},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.49286770820617676},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4907580316066742},{"id":"https://openalex.org/C2778496288","wikidata":"https://www.wikidata.org/wiki/Q6931269","display_name":"Mucositis","level":3,"score":0.48680397868156433},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.48341095447540283},{"id":"https://openalex.org/C114851261","wikidata":"https://www.wikidata.org/wiki/Q12147416","display_name":"Drug resistance","level":2,"score":0.4821590781211853},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.45571139454841614},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.44317418336868286},{"id":"https://openalex.org/C133936738","wikidata":"https://www.wikidata.org/wiki/Q643839","display_name":"Multiple drug resistance","level":3,"score":0.4387502074241638},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4313390254974365},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.2944512963294983},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C519063684","wikidata":"https://www.wikidata.org/wiki/Q706","display_name":"Calcium","level":2,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.0},{"id":"https://openalex.org/C87355193","wikidata":"https://www.wikidata.org/wiki/Q411","display_name":"Astrobiology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003907","descriptor_name":"Dexamethasone","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009101","descriptor_name":"Multiple Myeloma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009101","descriptor_name":"Multiple Myeloma","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D009101","descriptor_name":"Multiple Myeloma","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D012074","descriptor_name":"Remission Induction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014481","descriptor_name":"United States","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014700","descriptor_name":"Verapamil","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D014700","descriptor_name":"Verapamil","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D014700","descriptor_name":"Verapamil","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D014750","descriptor_name":"Vincristine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D015996","descriptor_name":"Survival Rate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018432","descriptor_name":"Drug Resistance, Multiple","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020168","descriptor_name":"ATP Binding Cassette Transporter, Subfamily B, Member 1","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1002/1097-0142(19950201)75:3<815::aid-cncr2820750311>3.0.co;2-r","doi":"https://doi.org/10.1002/1097-0142(19950201)75:3<815::aid-cncr2820750311>3.0.co;2-r","is_oa":true,"landing_page_url":"https://doi.org/10.1002/1097-0142(19950201)75:3<815::aid-cncr2820750311>3.0.co;2-r","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/1097-0142%2819950201%2975%3A3%3C815%3A%3AAID-CNCR2820750311%3E3.0.CO%3B2-R","source":{"id":"https://openalex.org/S126033908","display_name":"Cancer","issn_l":"0008-543X","issn":["0008-543X","1045-7410","1097-0142"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer","raw_type":"journal-article"},{"id":"pmid:7828131","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/7828131","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer","raw_type":"Clinical Trial"}],"best_oa_location":{"id":"doi:10.1002/1097-0142(19950201)75:3<815::aid-cncr2820750311>3.0.co;2-r","doi":"https://doi.org/10.1002/1097-0142(19950201)75:3<815::aid-cncr2820750311>3.0.co;2-r","is_oa":true,"landing_page_url":"https://doi.org/10.1002/1097-0142(19950201)75:3<815::aid-cncr2820750311>3.0.co;2-r","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/1097-0142%2819950201%2975%3A3%3C815%3A%3AAID-CNCR2820750311%3E3.0.CO%3B2-R","source":{"id":"https://openalex.org/S126033908","display_name":"Cancer","issn_l":"0008-543X","issn":["0008-543X","1045-7410","1097-0142"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[{"id":"https://openalex.org/G1439713495","display_name":"Columbus Community Clinical Oncology Program (Columbus CCOP)","funder_award_id":"U10CA035261","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G1646027999","display_name":null,"funder_award_id":"CA-35261","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G3065506811","display_name":"SOUTHWEST ONCOLOGY GROUP STATISTICAL CENTER","funder_award_id":"2u10ca038926-25","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G5515545788","display_name":"SOUTHWEST ONCOLOGY GROUP CA13612","funder_award_id":"U10CA013612","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G712978930","display_name":null,"funder_award_id":"CA 13612","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G763325562","display_name":null,"funder_award_id":"CA 38926","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2000375621.pdf","grobid_xml":"https://content.openalex.org/works/W2000375621.grobid-xml"},"referenced_works_count":27,"referenced_works":["https://openalex.org/W183223385","https://openalex.org/W1519046610","https://openalex.org/W1545285984","https://openalex.org/W1754065147","https://openalex.org/W1972264308","https://openalex.org/W2017239698","https://openalex.org/W2026392633","https://openalex.org/W2038933446","https://openalex.org/W2042367294","https://openalex.org/W2088419541","https://openalex.org/W2099704297","https://openalex.org/W2125205754","https://openalex.org/W2135923360","https://openalex.org/W2139330198","https://openalex.org/W2161983472","https://openalex.org/W2163636540","https://openalex.org/W2168070336","https://openalex.org/W2170255900","https://openalex.org/W2301279425","https://openalex.org/W2397577365","https://openalex.org/W2402432724","https://openalex.org/W2404356933","https://openalex.org/W2414723303","https://openalex.org/W2437802176","https://openalex.org/W2615953705","https://openalex.org/W4237253263","https://openalex.org/W4298330584"],"related_works":["https://openalex.org/W2301279425","https://openalex.org/W2465556950","https://openalex.org/W2075427940","https://openalex.org/W2040342801","https://openalex.org/W2468000500","https://openalex.org/W1754065147","https://openalex.org/W2070243196","https://openalex.org/W2170255900","https://openalex.org/W1997523827","https://openalex.org/W1972464435"],"abstract_inverted_index":{"BACKGROUND:":[0],"Multiple":[1],"myeloma":[2,66,200],"is":[3,13,36],"considered":[4],"to":[5,82,84,176,190,210],"be":[6],"a":[7,79,130],"drug":[8,25,30,63],"responsive":[9],"disease;":[10],"however,":[11],"there":[12],"no":[14],"cure":[15],"for":[16,111,118,136,143,153,195],"this":[17],"disease":[18],"and":[19,53,56,89,116,140,174,204],"virtually":[20],"all":[21],"patients":[22,67,125],"will":[23],"develop":[24],"resistance.":[26],"One":[27],"form":[28],"of":[29,47,50,109,124,133,169,187,198,214],"resistance":[31,39],"that":[32],"has":[33],"been":[34],"documented":[35],"the":[37,48,71,91,98,112,119,137,144,159,185,191,196,212,220],"multidrug":[38],"phenotype":[40],"or":[41,86],"MDR.":[42],"METHODS:":[43],"A":[44],"randomized":[45],"trial":[46],"combination":[49],"vincristine,":[51],"doxorubicin,":[52],"dexamethasone":[54],"(VAD)":[55],"VAD":[57,113,138,192],"plus":[58],"oral":[59,188],"verapamil":[60,172,189],"(VAD/v)":[61],"in":[62,216,219],"refractory":[64],"multiple":[65],"was":[68,76,126,150,165,182],"performed":[69],"by":[70],"Southwestern":[72],"Oncology":[73],"Group.":[74],"Verapamil":[75],"used":[77],"as":[78],"chemosensitizing":[80],"agent":[81],"attempt":[83],"overcome":[85],"prevent":[87],"MDR":[88,218],"improve":[90],"therapeutic":[92],"outcome.":[93],"RESULTS:":[94],"Response":[95],"rates":[96],"between":[97,167],"two":[99],"treatment":[100,197],"arms":[101],"were":[102],"similar":[103,128,152],"with":[104,129,156],"an":[105],"overall":[106],"response":[107,175],"rate":[108],"41%":[110],"alone":[114],"arm":[115,139],"36%":[117],"VAD/v":[120,145],"arm.":[121,146],"Overall":[122],"survival":[123,132],"also":[127,151],"median":[131],"10":[134],"months":[135,142],"13":[141],"The":[147],"toxicity":[148],"profile":[149],"both":[154],"treatments,":[155],"myelosuppression":[157],"being":[158],"dose-limiting":[160],"toxicity.":[161],"No":[162,179],"significant":[163],"correlation":[164],"observed":[166,183],"expression":[168],"P-glycoprotein,":[170],"serum":[171],"levels,":[173],"therapy.":[177],"CONCLUSIONS:":[178],"beneficial":[180],"effect":[181],"from":[184],"addition":[186],"chemotherapy":[193],"regimen":[194],"drug-resistant":[199],"patients.":[201],"More":[202],"effective":[203],"less":[205],"toxic":[206],"chemosensitizers":[207,215],"are":[208],"needed":[209],"study":[211],"role":[213],"reversing":[217],"clinic.":[221]},"counts_by_year":[{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":9},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}